Radiobiological and Clinical Advantages of Proton Therapy in Modern Cancer Treatment
Authors:
- Spyridon A. KalospyrosSKSpyridon A. Kalospyros
- Angeliki GkikoudiAGAngeliki Gkikoudi
- Athanasios KoutsostathisAKAthanasios Koutsostathis
- Athanasia AdamopoulouAAAthanasia Adamopoulou
- Spyridon N. VasilopoulosSVSpyridon N. Vasilopoulos
- Vasileios RangosVRVasileios Rangos
- Erato Stylianou-MarkidouESErato Stylianou-Markidou
- Ioannis PantalosIPIoannis Pantalos
- Constantinos KoumenisCKConstantinos Koumenis
- Alexandros G. GeorgakilasAlexandros G. Georgakilas
Open Access
Abstract
Background/Objectives: Proton therapy has emerged as an advanced radiotherapy modality due to its unique physical dose distribution and its distinct radiobiological properties. The finite range of protons in tissue enables highly conformal dose delivery with minimal exit dose, significantly reducing irradiation of surrounding normal tissues compared to photon-based radiotherapy. Beyond these physical advantages, proton beams exhibit a spatially varying linear energy transfer that increases toward the distal edge of the spread-out Bragg peak, leading to clustered and complex DNA damage that is more difficult for cancer cells to repair. Methods: This review integrates experimental, computational, and clinical evidence to examine how proton-induced DNA damage, relative biological effectiveness, oxygen effects, and non-targeted responses contribute to tumor control and normal tissue sparing. Results: Comparative analyses with photon intensity-modulated radiotherapy demonstrate consistent reductions in acute and late toxicities across multiple tumor sites, particularly in pediatric patients and in tumors located near critical organs. The review also discusses emerging technologies, including pencil beam scanning, image-guided and adaptive proton therapy, compact accelerator systems, and ultra-high dose rate FLASH proton therapy, which collectively aim to enhance treatment precision, biological effectiveness, and accessibility. Conclusions: Together, these developments support proton therapy as a rapidly evolving modality with significant potential to improve therapeutic outcomes in modern oncology.Keywords
This publication has 88 references indexed in Scilit:
- A meta‐analysis comparing efficacy and safety between proton beam therapy versus carbon ion radiotherapyCancer Medicine, 2024
- Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone MetastasesJAMA Oncology, 2023
- Second cancer risk after primary cancer treatment with three‐dimensional conformal, intensity‐modulated, or proton beam radiation therapyCancer, 2020
- A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal CancerAdvances in Radiation Oncology, 2019
- Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in childrenCancer, 2015
- Highly effective treatment of skull base chordoma with carbon ion irradiation using a raster scan technique in 155 patients: First long‐term resultsCancer, 2014
- Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastomaCancer, 2013
- Fish “painting” patterns resulting from complex exchangesMutation Research/Environmental Mutagenesis and Related Subjects, 1994
- The proton treatment center at Loma Linda University Medical Center: Rationale for and description of its developmentInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1992
- Proton irradiation of the pituitaryCancer, 1957